Literature DB >> 22503751

Slug expression during melanoma progression.

Stephanie H Shirley1, Victoria R Greene, Lyn M Duncan, Carlos A Torres Cabala, Elizabeth A Grimm, Donna F Kusewitt.   

Abstract

Slug (Snai2), a member of the Snail family of zinc finger transcription factors, plays a role in the epithelial-to-mesenchymal transformation (EMT) that occurs during melanocyte emigration from the neural crest. A role for Slug in the EMT-like loss of cell adhesion and increased cell motility exhibited during melanoma progression has also been proposed. Our immunohistochemical studies of melanoma arrays, however, revealed that Slug expression was actually higher in nevi than in primary or metastatic melanomas. Moreover, Slug expression in melanomas was not associated with decreased expression of E-cadherin, the canonical Slug target in EMT. Comparisons of endogenous Slug and E-cadherin expression in cultured normal human melanocytes and melanoma cell lines supported our immunohistochemical findings. Expression of exogenous Slug in melanocytes and melanoma cells in vitro, however, suppressed E-cadherin expression, enhanced N-cadherin expression, and stimulated cell migration and invasion. Interestingly, both in tumors and cultured cell lines, there was a clear relationship between expression of Slug and MITF, a transcription factor known to regulate Slug expression during development. Taken together, our findings suggest that Slug expression during melanomagenesis is highest early in the process and that persistent Slug expression is not required for melanoma progression. The precise role of Slug in melanomagenesis remains to be elucidated and may be related to its interactions with other drivers of EMT, such as Snail.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503751      PMCID: PMC3378849          DOI: 10.1016/j.ajpath.2012.02.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

1.  Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.

Authors:  I Poser; D Domínguez; A G de Herreros; A Varnai; R Buettner; A K Bosserhoff
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 3.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

4.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

Review 5.  The Met tyrosine kinase receptor in development and cancer.

Authors:  Alessandra Gentile; Livio Trusolino; Paolo M Comoglio
Journal:  Cancer Metastasis Rev       Date:  2008-03       Impact factor: 9.264

Review 6.  Transcription factors involved in development and progression of malignant melanoma.

Authors:  I Poser; A-K Bosserhoff
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

7.  Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.

Authors:  Mathew J Joseph; Surabhi Dangi-Garimella; Mario A Shields; Michelle E Diamond; Limin Sun; Jennifer E Koblinski; Hidayatullah G Munshi
Journal:  J Cell Biochem       Date:  2009-10-15       Impact factor: 4.429

8.  Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

Authors:  Ivan Vannini; Massimiliano Bonafe; Anna Tesei; Marco Rosetti; Francesco Fabbri; Gianluca Storci; Paola Ulivi; Giovanni Brigliadori; Dino Amadori; Wainer Zoli
Journal:  Cell Oncol       Date:  2007       Impact factor: 6.730

Review 9.  Analysis of the E-cadherin repressor Snail in primary human cancers.

Authors:  K-F Becker; E Rosivatz; K Blechschmidt; E Kremmer; M Sarbia; H Höfler
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

10.  Regulative response of the cranial neural tube after neural fold ablation: spatiotemporal nature of neural crest regeneration and up-regulation of Slug.

Authors:  J Sechrist; M A Nieto; R T Zamanian; M Bronner-Fraser
Journal:  Development       Date:  1995-12       Impact factor: 6.868

View more
  29 in total

1.  Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.

Authors:  G Denecker; N Vandamme; O Akay; D Koludrovic; J Taminau; K Lemeire; A Gheldof; B De Craene; M Van Gele; L Brochez; G M Udupi; M Rafferty; B Balint; W M Gallagher; G Ghanem; D Huylebroeck; J Haigh; J van den Oord; L Larue; I Davidson; J-C Marine; G Berx
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

Review 2.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

3.  Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.

Authors:  F Vand-Rajabpour; N Sadeghipour; S Saee-Rad; H Fathi; P Noormohammadpour; M Yaseri; K K Hesari; Z Bagherpour; M Tabrizi
Journal:  Clin Transl Oncol       Date:  2016-10-07       Impact factor: 3.405

Review 4.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

Review 5.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

6.  GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.

Authors:  Jobin K John; Kim H T Paraiso; Vito W Rebecca; Liliana P Cantini; Ethan V Abel; Nicholas Pagano; Eric Meggers; Rahel Mathew; Clemens Krepler; Victoria Izumi; Bin Fang; John M Koomen; Jane L Messina; Meenhard Herlyn; Keiran S M Smalley
Journal:  J Invest Dermatol       Date:  2012-07-19       Impact factor: 8.551

Review 7.  Insights into neural crest development and evolution from genomic analysis.

Authors:  Marcos Simões-Costa; Marianne E Bronner
Journal:  Genome Res       Date:  2013-07       Impact factor: 9.043

8.  Ultraviolet radiation and the slug transcription factor induce proinflammatory and immunomodulatory mediator expression in melanocytes.

Authors:  Stephanie H Shirley; Elizabeth A Grimm; Donna F Kusewitt
Journal:  J Skin Cancer       Date:  2012-06-13

9.  Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines.

Authors:  Ji Eun Kim; Euphemia Leung; Bruce C Baguley; Graeme J Finlay
Journal:  Front Genet       Date:  2013-05-31       Impact factor: 4.599

10.  Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.

Authors:  Maria Wehbe; Saïdi M Soudja; Amandine Mas; Lionel Chasson; Rodolphe Guinamard; Céline Powis de Tenbossche; Grégory Verdeil; Benoît Van den Eynde; Anne-Marie Schmitt-Verhulst
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.